RedHill Biopharma Wraps Up Recruitment for Phase 3 Trial of RHB-104 for Crohn’s
News
RedHill Biopharma has finished recruiting the 331 participants it wanted for a Phase 3 clinical trial of RHB-104 as a treatment for Crohn’s disease. About two-thirds of the participants have already completed the ... Read more